mushroomreferences.com – Page 6 – A Curated List of References Relevant to Physicians, Scientists, and the Intellectually Curious

RATIONALE: Ketamine and psilocybin belong to the rapid-acting antidepressants but they also produce psychotomimetic effects including timing distortion. It is currently debatable whether these are…

Effects of ketamine optical isomers, psilocybin, psilocin and norpsilocin on time estimation and cognition in rats

In Vitro Efficacy of Bracket Fungi for Their Potential Antimicrobial Activity

Identification of ω-N-Methyl-4-hydroxytryptamine (Norpsilocin) as a Psilocybe Natural Product

Production and extraction of psilocybin and psilocin from Psilocybe spp. mushrooms

Psilocybin targets a common molecular mechanism for cognitive impairment and increased craving in alcoholism

Erinacine A Prevents Lipopolysaccharide-Mediated Glial Cell Activation to Protect Dopaminergic Neurons against Inflammatory Factor-Induced Cell Death In Vitro and In Vivo

Water Extract of the Chaga Medicinal Mushroom Inonotus obliquus (Agaricomycetes) Inhibits the SARS-Cov-2 Replication at Vero E6 and Vero Cell Cultures Experiments

The effects of psilocybin on cognitive and emotional functions in healthy participants: Results from a phase 1, randomised, placebo-controlled trial involving simultaneous psilocybin administration and preparation

Erinacine A-Enriched Hericium erinaceus Mycelium Delays Progression of Age-Related Cognitive Decline in Senescence Accelerated Mouse Prone 8 (SAMP8) Mice

Hericium erinaceus mycelium ameliorate anxiety induced by continuous sleep disturbance in vivo

Functional neuroimaging correlates of finger-tapping task variations: an ALE meta-analysis

Acute and Sustained Reductions in Loss of Meaning and Suicidal Ideation Following Psilocybin-Assisted Psychotherapy for Psychiatric and Existential Distress in Life-Threatening Cancer

Neuroprotective Metabolites of Hericium erinaceus Promote Neuro-Healthy Aging

Acute psychological and physiological effects of psilocybin in healthy humans: a double-blind, placebo-controlled dose–effect study

Exposure-Response Analysis to Assess the Concentration-QTc Relationship of Psilocybin/Psilocin

Preclinical Bioavailability, Tissue Distribution, and Protein Binding Studies of Erinacine A, a Bioactive Compound from Hericium erinaceus Mycelia Using Validated LC-MS/MS Method

Cortical activations during paces finger-tapping applying visual and auditory pacing stimuli

Fortified Mycelium of Fomitopsis officinalis (Agaricomycetes) as a Source of Biologically Active Substances Effective in the Prevention of Civilization Diseases

The effect of nerve growth factor on supporting spatial memory depends upon hippocampal cholinergic innervation

Hericium erinaceus and Coriolus versicolor Modulate Molecular and Biochemical Changes after Traumatic Brain Injury

People of color in North America report improvements in racial trauma and mental health symptoms following psychedelic experiences

Pharmacologic Similarities and Differences Among Hallucinogens

Psilocybin as a New Approach to Treat Depression and Anxiety in the Context of Life-Threatening Diseases-A Systematic Review and Meta-Analysis of Clinical Trials

Psilocybin: From Serendipity to Credibility?

Psilocybin Induces Time-Dependent Changes in Global Functional Connectivity

The pharmacology of psilocybin

Sustained, Multifaceted Improvements in Mental Well-Being Following Psychedelic Experiences in a Prospective Opportunity Sample

Psychedelic effects of psilocybin correlate with serotonin 2A receptor occupancy and plasma psilocin levels

The Therapeutic Potential of Psilocybin

The therapeutic potential of microdosing psychedelics in depression